NO20085243L - Farmasoytisk sammensetning til behandling av virusinfeksjoner og/eller tumorsykdommer gjennom inhibering av proteinfolding og Proteinnedbryting - Google Patents
Farmasoytisk sammensetning til behandling av virusinfeksjoner og/eller tumorsykdommer gjennom inhibering av proteinfolding og ProteinnedbrytingInfo
- Publication number
- NO20085243L NO20085243L NO20085243A NO20085243A NO20085243L NO 20085243 L NO20085243 L NO 20085243L NO 20085243 A NO20085243 A NO 20085243A NO 20085243 A NO20085243 A NO 20085243A NO 20085243 L NO20085243 L NO 20085243L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- pharmaceutical composition
- protein
- inhibition
- viral infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Oppfinnelsen angår en farmasøytisk sammensetning som omfatter som virksomme komponenter minst én proteasominhibitor og én inhibitor av proteinfoldingsenzymer. Midlene er egnet til behandling av akutte og kroniske infeksjoner med patogene virus for mennesker og dyr.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006026464A DE102006026464A1 (de) | 2006-06-01 | 2006-06-01 | Pharmazeutische Zusammensetzung zur Behandlung von Virusinfektionen und / oder Tumorerkrankungen durch Inhibition der Proteinfaltung und des Proteinabbaus |
PCT/EP2007/055425 WO2007138116A2 (de) | 2006-06-01 | 2007-06-01 | Pharmazeutische zusammensetzung zur behandlung von virusinfektionen und/oder tumorerkrankungen durch inhibition der proteinfaltung und des proteinabbaus |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20085243L true NO20085243L (no) | 2009-02-27 |
Family
ID=38626699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20085243A NO20085243L (no) | 2006-06-01 | 2008-12-15 | Farmasoytisk sammensetning til behandling av virusinfeksjoner og/eller tumorsykdommer gjennom inhibering av proteinfolding og Proteinnedbryting |
Country Status (15)
Country | Link |
---|---|
US (1) | US20090156473A1 (no) |
EP (1) | EP2029125A2 (no) |
JP (1) | JP2009538881A (no) |
KR (1) | KR20090048403A (no) |
CN (1) | CN101453998A (no) |
AU (1) | AU2007267082A1 (no) |
BR (1) | BRPI0712459A2 (no) |
CA (1) | CA2654276A1 (no) |
DE (1) | DE102006026464A1 (no) |
IL (1) | IL195611A0 (no) |
MX (1) | MX2008015259A (no) |
NO (1) | NO20085243L (no) |
RU (1) | RU2008152796A (no) |
WO (1) | WO2007138116A2 (no) |
ZA (1) | ZA200810531B (no) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7176232B2 (en) | 2002-06-24 | 2007-02-13 | The Regents Of The University Of California | Salinosporamides and methods for use thereof |
US8198270B2 (en) * | 2004-04-15 | 2012-06-12 | Onyx Therapeutics, Inc. | Compounds for proteasome enzyme inhibition |
SG152239A1 (en) | 2004-04-15 | 2009-05-29 | Proteolix Inc | Compounds for proteasome enzyme inhibition |
WO2005111008A2 (en) * | 2004-05-10 | 2005-11-24 | Proteolix, Inc. | Compounds for enzyme inhibition |
JP5676071B2 (ja) | 2004-12-03 | 2015-02-25 | ダナ ファーバー キャンサー インスティテュート,インコーポレイテッド | 腫瘍性疾患を治療するための組成物及び方法 |
PL2623113T3 (pl) | 2005-11-09 | 2018-05-30 | Onyx Therapeutics, Inc. | Związek do hamowania enzymu |
SI2041158T1 (sl) * | 2006-06-19 | 2013-09-30 | Onyx Therapeutics, Inc. | Peptidni epoksiketoni za inhibicijo proteasomov |
WO2008095195A2 (en) | 2007-02-02 | 2008-08-07 | Nereus Pharmaceuticals, Inc. | Lyophilized formulations of salinosporamide a |
US20080280968A1 (en) * | 2007-05-04 | 2008-11-13 | Nereus Pharmaceuticals, Inc. | Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases |
DE102007031397A1 (de) | 2007-07-05 | 2009-01-08 | D2O Bioscience Group Ltd. | Verwendung von Deuteriumoxid zur Behandlung von Virus-basierten Erkrankungen der Haut |
ES2684340T3 (es) | 2007-10-04 | 2018-10-02 | Onyx Therapeutics, Inc. | Inhibidores de proteasa epoxi cetona de péptidos cristalinos y síntesis de cetoepóxidos de aminoácidos |
JP5468015B2 (ja) * | 2008-01-08 | 2014-04-09 | アクセリア ファーマシューティカルズ | 抗菌ペプチド系に対する作動薬 |
BRPI0912234A2 (pt) | 2008-05-12 | 2015-10-06 | Nereus Pharmaceuticals Inc | derivados de salinosporamida como inibidores de proteassomas |
US20110236428A1 (en) | 2008-10-21 | 2011-09-29 | Onyx Therapeutics, Inc. | Combination therapy with peptide epoxyketones |
DE102009003942A1 (de) * | 2009-01-07 | 2010-07-08 | D2O Biosience Group Ltd., Hamilton | Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges |
DE102009003992A1 (de) * | 2009-01-07 | 2010-07-08 | D2O Biosience Group Ltd., Hamilton | Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Respirationstraktes |
TWI504598B (zh) | 2009-03-20 | 2015-10-21 | Onyx Therapeutics Inc | 結晶性三肽環氧酮蛋白酶抑制劑 |
JP2013500265A (ja) * | 2009-07-23 | 2013-01-07 | ザ トラスティーズ オブ プリンストン ユニバーシティ | 抗ウイルス剤として用いられるmTORキナーゼ阻害剤 |
EP2467144A1 (en) * | 2009-07-24 | 2012-06-27 | ViroLogik GmbH | Combination of proteasome inhibitors and anti-hepatitis medication for treating hepatitis |
CN102051407B (zh) * | 2009-11-09 | 2012-12-12 | 中国医学科学院医药生物技术研究所 | Hiv-1前体蛋白早成熟化诱导剂的筛选方法 |
JP5919196B2 (ja) | 2009-11-13 | 2016-05-18 | オニキス セラピューティクス, インク.Onyx Therapeutics, Inc. | 転移抑制のためのペプチドエポキシケトンの使用 |
WO2011096756A2 (ko) * | 2010-02-04 | 2011-08-11 | 이화여자대학교 산학협력단 | 비정상적 세포 증식 억제용 약제학적 조성물 |
AU2011223795B2 (en) | 2010-03-01 | 2015-11-05 | Onyx Therapeutics, Inc. | Compounds for immunoproteasome inhibition |
EP2555621A4 (en) | 2010-04-07 | 2014-07-02 | Onyx Therapeutics Inc | CRYSTALLINE EPOXYCETONE PEPTIDE IMMUNOPROTEASOME INHIBITOR |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
ES2529143B1 (es) | 2011-10-21 | 2015-10-26 | Abbvie Inc. | Combinación de al menos dos agentes antivirales de acción directa, ribavirina pero no interferón para uso de tratamiento del vhc |
PT107925A (pt) | 2011-10-21 | 2014-12-03 | Abbvie Inc | Tratamento de combinação de daa (eg. com abt-072 ou abt-333) para utilização no tratamento de hcv |
JP6028968B2 (ja) * | 2012-02-24 | 2016-11-24 | 学校法人順天堂 | 抗インフルエンザウイルス剤 |
EP2869820A4 (en) | 2012-07-09 | 2016-02-17 | Onyx Therapeutics Inc | PRODRUGS OF PEPTIDEPOXIDE KETONE PROTEASE INHIBITORS |
CN105477007B (zh) * | 2014-09-15 | 2020-02-18 | 中国医学科学院药物研究所 | 大环内酯类药物在抗丝状病毒感染中的应用 |
CN105675572B (zh) * | 2016-03-15 | 2018-09-14 | 四川大学华西医院 | 一种肺癌筛查试剂盒 |
WO2017189978A1 (en) | 2016-04-28 | 2017-11-02 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
US11266675B2 (en) * | 2018-04-30 | 2022-03-08 | City University Of Hong Kong | Methods of treatment of viral infection and uses of anti-HSC70 inhibitors |
CN108635584B (zh) * | 2018-05-22 | 2021-12-21 | 广州威溶特医药科技有限公司 | 蛋白酶体抑制剂和甲病毒在制备抗肿瘤药物中的应用 |
CN110133286A (zh) * | 2019-05-20 | 2019-08-16 | 吉林大学 | Hsp60基因作为靶点在脑膜炎治疗中的医用用途 |
CN111514299A (zh) * | 2020-04-29 | 2020-08-11 | 广州中医药大学科技产业园有限公司 | 一种用于防治肺炎的组合物及其在制备用于防治肺炎的药物中的应用 |
US20230181607A1 (en) * | 2020-05-13 | 2023-06-15 | The University of the Regents of California | Thiosaccharides for use in treating coronavirus infection |
WO2021263139A1 (en) * | 2020-06-26 | 2021-12-30 | Duke University | Methods of treating coronavirus infection using hsp90 inhibitors |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083903A (en) | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
CA2219867A1 (en) * | 1997-10-31 | 1999-04-30 | Jiangping Wu | The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
US20020049157A1 (en) * | 1999-08-25 | 2002-04-25 | Jiangping Wu | Use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
ES2272558T3 (es) * | 2000-10-12 | 2007-05-01 | Viromics Gmbh | Inhibidores del proteasoma para el tratamiento de infecciones causadas por virus de la hepatitis. |
WO2002080907A1 (en) * | 2001-04-03 | 2002-10-17 | Millennium Pharmaceuticals, Inc. | Combination of lactacystin analog and immunosuppressive drug for the prolongation of allograft survival |
DE10361944A1 (de) * | 2003-12-31 | 2005-07-28 | Viromics Gmbh | Mittel zur Hemmung der Virusreplikation durch Regulation der Proteinfaltung |
WO2005115431A2 (en) * | 2004-05-24 | 2005-12-08 | Adonia Papathanassiu | Methods for inhibiting proteasome and heat shock protein 90 |
KR20080007642A (ko) * | 2005-04-29 | 2008-01-22 | 코산 바이오사이언시즈, 인코포레이티드 | 프로테아좀 억제제와 함께 17-aag 또는 17-ag 또는 둘중 하나의 전구약물을 사용하여 다발성 골수종을 치료하는방법 |
WO2007059116A2 (en) * | 2005-11-14 | 2007-05-24 | Abraxis Bioscience, Inc. | Geldanamycin derivatives and pharmaceutical compositions thereof |
-
2006
- 2006-06-01 DE DE102006026464A patent/DE102006026464A1/de not_active Withdrawn
-
2007
- 2007-06-01 JP JP2009512618A patent/JP2009538881A/ja active Pending
- 2007-06-01 AU AU2007267082A patent/AU2007267082A1/en not_active Abandoned
- 2007-06-01 MX MX2008015259A patent/MX2008015259A/es not_active Application Discontinuation
- 2007-06-01 BR BRPI0712459-7A patent/BRPI0712459A2/pt not_active IP Right Cessation
- 2007-06-01 CN CNA2007800197060A patent/CN101453998A/zh active Pending
- 2007-06-01 WO PCT/EP2007/055425 patent/WO2007138116A2/de active Application Filing
- 2007-06-01 RU RU2008152796/15A patent/RU2008152796A/ru not_active Application Discontinuation
- 2007-06-01 CA CA002654276A patent/CA2654276A1/en not_active Abandoned
- 2007-06-01 EP EP07765312A patent/EP2029125A2/de not_active Withdrawn
- 2007-06-01 KR KR1020087032197A patent/KR20090048403A/ko not_active Application Discontinuation
-
2008
- 2008-11-30 IL IL195611A patent/IL195611A0/en unknown
- 2008-12-01 US US12/325,598 patent/US20090156473A1/en not_active Abandoned
- 2008-12-12 ZA ZA200810531A patent/ZA200810531B/xx unknown
- 2008-12-15 NO NO20085243A patent/NO20085243L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2654276A1 (en) | 2007-12-06 |
AU2007267082A1 (en) | 2007-12-06 |
RU2008152796A (ru) | 2010-07-20 |
CN101453998A (zh) | 2009-06-10 |
JP2009538881A (ja) | 2009-11-12 |
ZA200810531B (en) | 2009-11-25 |
MX2008015259A (es) | 2009-03-26 |
BRPI0712459A2 (pt) | 2012-07-31 |
DE102006026464A1 (de) | 2007-12-06 |
WO2007138116A2 (de) | 2007-12-06 |
KR20090048403A (ko) | 2009-05-13 |
IL195611A0 (en) | 2009-09-01 |
EP2029125A2 (de) | 2009-03-04 |
WO2007138116A3 (de) | 2008-05-08 |
US20090156473A1 (en) | 2009-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20085243L (no) | Farmasoytisk sammensetning til behandling av virusinfeksjoner og/eller tumorsykdommer gjennom inhibering av proteinfolding og Proteinnedbryting | |
MY141003A (en) | Materials and methods for treating viral infections with a cysteamine compound | |
BRPI0418251C1 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
CY1111212T1 (el) | Θειικες ενωσεις ως αναστολεις της πρωτεασης σερινης ns3 του ιου της ηπατιτιδας γ | |
CY1112383T1 (el) | Αναστολεις της πρωτεϊνης ενεργοποιησης της 5-λιποξυγενασης (flap) | |
EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
ECSP099685A (es) | Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c | |
EA200901308A1 (ru) | Ингибиторы белка, активирующего 5-липоксигеназу (flap) | |
BR112012024661A2 (pt) | composto, composição farmacêutica e método de tratamento de um hospedeiro infectado com vírus de hepatite c | |
CR9949A (es) | Inhibidores de proteina activadora de la 5-lipoxigenasa (flap) | |
BRPI0606524A2 (pt) | derivados de indol para o tratamento de infecções virais | |
BRPI0612309B8 (pt) | compostos e composições farmacêuticas antivirais | |
ZA200805304B (en) | Anti-viral compounds | |
EA200900298A1 (ru) | Ингибиторы вируса гепатита с | |
WO2008133753A3 (en) | Anti-viral compounds | |
EA200870164A1 (ru) | Лечение вирусного гепатита | |
BRPI0411900B8 (pt) | compostos e composições farmacêuticas compreendendo os mesmos | |
EA200800178A1 (ru) | Ингибиторы вируса гепатита с (hcv) | |
EA200970916A1 (ru) | Соединения 5,6-дигидро-1н-пиридин-2-она | |
EA200901241A1 (ru) | Соединения для лечения гепатита с | |
EA201170441A1 (ru) | Терапевтические противовирусные пептиды | |
EA200970483A1 (ru) | Применение пролекарств габапентина и прегабалина для лечения шума в ушах | |
EA201000277A1 (ru) | Соединения для лечения гепатита с | |
CL2008002092A1 (es) | Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas. | |
EA201171273A1 (ru) | Средство для профилактики и лечения высокопатогенных инфекционных заболеваний |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |